Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Novartis to appeal Zelnorm rejection

January 18, 2006 Sales and Marketing

Novartis says it will appeal against an EMEA decision not to recommend its irritable bowel syndrome drug Zelnorm. Zelnorm (tegaserod) …
News

Prescribers ready to defy NICE in Alzheimer’s drug row

January 18, 2006 Sales and Marketing

Patient groups and manufacturers are hoping NICE will reverse its decision to deny access to Alzheimer's drugs on the NHS, …
News

First-in-class indication expected for Remicade

January 18, 2006 Sales and Marketing

Schering-Plough expects its arthritis treatment Remicade to receive European approval to treat ulcerative colitis in early 2006.If approved Remicade (infliximab) …
News

Merck in race to bring first cervical cancer vaccine to market

January 18, 2006 Sales and Marketing

Merck and GlaxoSmithKline are head-to-head in a race to establish a market for their rival cervical cancer vaccines, both set …
News

Drinking straw a novel antibiotic delivery for children

January 17, 2006 Sales and Marketing

A new drinking straw that administers antibiotics to children as they drink has been launched by German pharma company Grunenthal.Clarosip …
News

Pfizer to go it alone with Exubera

January 16, 2006 Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

 Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …
News

Bayer buys hypertension drug rights from GSK

January 12, 2006 Sales and Marketing

Bayer has bought the rights to market the hypertension drug telmisartan in a number of European markets from current licence …
News

New dawn or beginning of the end? Medicare D comes of age

January 12, 2006 Sales and Marketing

Millions of Americans woke up on 1 January 2006 and found themselves in an unfamiliar position  having their prescription medicine …
News

GlaxoSmithKline considering Serono acquisition

January 12, 2006 Sales and Marketing

GlaxoSmithKline is understood to be considering the acquisition of Europe's biggest biotech company Serono, currently worth around $12 billion.Serono's chief …
News

Bird flu tops 2005 global health concerns

December 22, 2005 Sales and Marketing

A survey conducted by the World Health Organisation has confirmed concerns over a possible bird flu pandemic as the year's …
News

Tamiflu-resistant bird flu found

December 22, 2005 Sales and Marketing

A report of two cases of bird flu which proved resistant to treatment with Tamiflu have been reported in the …
News

FDA approves Bayer’s kidney cancer drug

December 22, 2005 Sales and Marketing

Bayer's Nexavar has become the first treatment in more than ten years to receive approval in the US for the …
News

Pfizer lifted by Lipitor patent victory

December 20, 2005 Sales and Marketing

Shares in Pfizer have risen after it saw off a patent challenge to Lipitor, its biggest selling drug.Lipitor generates around …
News

Right-sizing the salesforce

December 20, 2005 Sales and Marketing salesforce

 Can we form an impression about how good or ‘right’ a team is simply by the size of it? We …
Feature

Prexige wins approval in UK

December 15, 2005 Sales and Marketing

Prexige has finally been launched in the UK after a safety review of the entire Cox-II class delayed its entrance …
News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026